General Info

ImmuneRegen BioSciences Inc. is a wholly owned subsidiary of IR BioSciences Holdings Inc., which is a development-stage biotechnology company. It is engaged in the research and development of the potential drug candidate, Homspera, as well as its derivatives. The biotechnology company develops drug candidates for regenerating or strengthening the human immune system through stimulation of human adult stem cells. ImmuneRegen BioSciences Inc. holds partnerships with some of the leading companies, including Tandem Labs, BioCure, STEMCELL Technologies, Celgene, Nelson Laboratories, VaxDesign, DelSite Biotechnologies Inc. and Lancaster Laboratories. In 2009, the company entered into a partnership with Bachem, Inc. for manufacturing Homspera.